|
1
|
Tsukada Y, Fouad A, Pickren JW and Lane
WW: Central nervous system metastasis from breast carcinoma.
Autopsy study. Cancer. 52:2349–2354. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kennecke H, Yerushalmi R, Woods R, Cheang
MC, Voduc D, Speers CH, Nielsen TO and Gelmon K: Metastatic
behavior of breast cancer subtypes. J Clin Oncol. 28:3271–3277.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aversa C, Rossi V, Geuna E, Martinello R,
Milani A, Redana S, Valabrega G, Aglietta M and Montemurro F:
Metastatic breast cancer subtypes and central nervous system
metastases. Breast. 23:623–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Soni A, Ren Z, Hameed O, Chanda D, Morgan
CJ, Siegal GP and Wei S: Breast cancer subtypes predispose the site
of distant metastases. Am J Clin Pathol. 143:471–478. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brufsky AM, Mayer M, Rugo HS, Kaufman PA,
Tan-Chiu E, Tripathy D, Tudor IC, Wang LI, Brammer MG, Shing M, et
al: Central nervous system metastases in patients with
HER2-positive metastatic breast cancer: Incidence, treatment, and
survival in patients from registHER. Clin Cancer Res. 17:4834–4843.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen Q, Sahin AA, Hess KR, Suki D, Aldape
KD, Sawaya R and Ibrahim NK: Breast cancer with brain metastases:
Clinicopathologic features, survival, and paired biomarker
analysis. Oncologist. 20:466–473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang B and Horvath S: A general framework
for weighted gene co-expression network analysis. Stat Appl Genet
Mol Biol. 4:Article172005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Horvath S, Zhang B, Carlson M, Lu KV, Zhu
S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, et al: Analysis
of oncogenic signaling networks in glioblastoma identifies ASPM as
a molecular target. Proc Natl Acad Sci USA. 103:17402–17407. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang L, Qi H, Xiao Y, Li C, Wang Y, Guo
T, Liu Z and Liu Q: Integrated analysis of noncoding RNAs and mRNAs
reveals their potential roles in the biological activities of the
growth hormone receptor. Growth Horm IGF Res. 29:11–20. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee J: Role of cyclophilin a during
oncogenesis. Arch Pharm Res. 33:181–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng J, Koblinski JE, Dutson LV, Feeney
YB and Clevenger CV: Prolyl isomerase cyclophilin A regulation of
Janus-activated kinase 2 and the progression of human breast
cancer. Cancer Res. 68:7769–7778. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Campa MJ, Wang MZ, Howard B, Fitzgerald MC
and Patz EF Jr: Protein expression profiling identifies macrophage
migration inhibitory factor and cyclophilin A as potential
molecular targets in non-small cell lung cancer. Cancer Res.
63:1652–1656. 2003.PubMed/NCBI
|
|
15
|
Cecconi D, Astner H, Donadelli M, Palmieri
M, Missiaglia E, Hamdan M, Scarpa A and Righetti PG: Proteomic
analysis of pancreatic ductal carcinoma cells treated with
5-aza-2′-deoxycytidine. Electrophoresis. 24:4291–4303. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Corton JC, Moreno ES, Merritt A, Bocos C
and Cattley RC: Cloning genes responsive to a hepatocarcinogenic
peroxisome proliferator chemical reveals novel targets of
regulation. Cancer Lett. 134:61–71. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chevalier F, Depagne J, Hem S, Chevillard
S, Bensimon J, Bertrand P and Lebeau J: Accumulation of cyclophilin
A isoforms in conditioned medium of irradiated breast cancer cells.
Proteomics. 12:1756–1766. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kenmochi N, Kawaguchi T, Rozen S, Davis E,
Goodman N, Hudson TJ, Tanaka T and Page DC: A map of 75 human
ribosomal protein genes. Genome Res. 8:509–523. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mager DL and Freeman JD: A human gene
related to the ribosomal protein L23 gene of Halobacterium
marismortui. Nucleic Acids Res. 18:53011990. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi Y, Zhai H, Wang X, Han Z, Liu C, Lan
M, Du J, Guo C, Zhang Y, Wu K and Fan D: Ribosomal proteins S13 and
L23 promote multidrug resistance in gastric cancer cells by
suppressing drug-induced apoptosis. Exp Cell Res. 296:337–346.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pflaum J, Schlosser S and Müller M: p53
family and cellular stress responses cancer. Front Oncol.
4:2852014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin A, Itahana K, O'Keefe K and Zhang Y:
Inhibition of HDM2 and activation of p53 by ribosomal protein L23.
Mol Cell Biol. 24:7669–7680. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang A, Kaghad M, Wang Y, Gillett E,
Fleming MD, Dötsch V, Andrews NC, Caput D and McKeon F: p63, a p53
homolog at 3q27-29, encodes multiple products with transactivating,
death-inducing, and dominant-negative activities. Mol Cell.
2:305–316. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Batistatou A, Stefanou D, Arkoumani E and
Agnantis NJ: The usefulness of p63 as a marker of breast
myoepithelial cells. In Vivo. 17:573–576. 2003.PubMed/NCBI
|
|
25
|
Barbareschi M, Pecciarini L, Cangi MG,
Macrì E, Rizzo A, Viale G and Doglioni C: p63, a p53 homologue, is
a selective nuclear marker of myoepithelial cells of the human
breast. Am J Surg Pathol. 25:1054–1060. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nylander K, Vojtesek B, Nenutil R,
Lindgren B, Roos G, Zhanxiang W, Sjöström B, Dahlqvist A and Coates
PJ: Differential expression of p63 isoforms in normal tissues and
neoplastic cells. J Pathol. 198:417–427. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leong CO, Vidnovic N, DeYoung MP, Sgroi D
and Ellisen LW: The p63/p73 network mediates chemosensitivity to
cisplatin in a biologically defined subset of primary breast
cancers. J Clin Invest. 117:1370–1380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koker MM and Kleer CG: p63 expression in
breast cancer-a highly sensitive and specific marker of metoplastic
carcinoma. Am J Surg Pathol. 28:1506–1512. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du Z, Li J, Wang L, Bian C, Wang Q, Liao
L, Dou X, Bian X and Zhao RC: Overexpression of Delta Np63 alpha
induces a stem cell phenotype in MCF7 breast carcinoma cell line
through the Notch pathway. Cancer Sci. 101:2417–2424. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Orzol P, Nekulova M, Holcakova J, Muller
P, Votesek B and Coates PJ: ΔNp63 regulates cell proliferation,
differentiation, adhesion, and migration in the BL2 subtype of
basal-like breast cancer. Tumour Biol. 37:10133–10140. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo M, Mengos AE, Ma W, Finlayson J,
Bustos RZ, Xiao Zhu Y, Shi CX, Stubblefield TM, Willis WT and
Mandarino LJ: Characterization of the novel protein KIAA0564 (Von
Willebrand Domain-containing Protein 8). Biochem Biophys Res
Commun. 487:545–551. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Romond EH, Jeong JH, Rastogi P, Swain SM,
Geyer CE Jr, Ewer MS, Rathi V, Fehrenbacher L, Brufsky A, Azar CA,
et al: Seven-year follow-up assessment of cardiac function in NSABP
B-31, a randomized trial comparing doxorubicin and cyclophosphamide
followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant
therapy for patients with node-positive, human epidermal growth
factor receptor 2-positive breast cancer. J Clin Oncol.
30:3792–3799. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Anders CK, Deal AM, Miller CR, Khorram C,
Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM and
Carey LA: The prognostic contribution of clinical Breast cancer
subtype, age, and race among patients with breast cancer brain
metastases. Cancer. 117:1602–1611. 2011. View Article : Google Scholar : PubMed/NCBI
|
